Evidence map›Paper›PMID 42269167›Full record

ArticleJMIR human factors2026

Good Clinical Practice Guidance for Line Materials, Filtration, and Light Protection in Intravenous Medication Administration: Modified Delphi Consensus Study.

Andrew Dickman, Penelope Tuffin, Rania Al-Jaber, Mona El-Harmeel, Jennifer Schneider, Irene Taladriz-Sender, Adam Sutherland, Robert Terkola, James Waterson

Abstract read
In one paragraph

Article in JMIR human factors, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Andrew DickmanLiverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.ORCID 0000-0001-6493-8979
Penelope TuffinFiona Stanley Hospital, Bethesda Hospital and Western Australia Country Health Service, Australia.ORCID 0000-0001-6856-8266
Rania Al-JaberKing Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.ORCID 0000-0002-4279-4502
Mona El-HarmeelChildren's Cancer Hospital, Cairo, Egypt.ORCID 0009-0005-6869-1009
Jennifer SchneiderSchool of Medicine and Public Health Faculty of Medicine and Health, Newcastle, Australia.ORCID 0000-0002-3473-8009
Irene Taladriz-SenderHospital General Universitario Gregorio Marañón, Madrid, Spain.ORCID 0000-0003-3261-6590
Adam SutherlandSchool of Pharmacy and Medical Sciences, University of Bradford, Bradford, United Kingdom.ORCID 0000-0002-5198-3727
Robert TerkolaParacelsus Medical University, Salzburg, Austria.ORCID 0000-0002-6915-2411
James WatersonBecton Dickinson and Company, Dubai, United Arab Emirates.ORCID 0000-0002-4100-5970

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is an unmet need for reliable medication stability information to avoid suboptimal administration of intravenous medications, which may lead to reduced efficacy of therapy and potential patient harm through medication degradation or incompatibilities that cause vascular access issues.

objectiveThis study aimed to develop evidence-informed guidance for pharmacists and nurses on the use of administration line materials, in-line filtration, and light protection during storage and intravenous administration of medications commonly used in critical care and oncology.

methodsAn initial list of 181 medications was compiled in consultation with pharmacist stakeholders from critical care and oncology specialties. A modified Delphi study was conducted over 3 rounds with a panel of 8 expert pharmacists selected for their clinical expertise, professional experience, and geographic location to ensure representation of diverse health care settings and medication administration practices. Panelists anonymously ranked statements on a 5-point Likert scale developed from a review of the literature with respect to the requirement for a specific administration line material for each medication; the need for, and type of, filtration required during administration; and the need for light protection during storage and administration of medications. After each round, items achieving 80% consensus were finalized. Those that did not achieve consensus were carried forward to the next round. This iterative approach allowed panelists to reconsider their ratings based on emerging group consensus and additional evidence shared by panelists between rounds.

resultsA total of 1044 administration and storage requirements were assessed for a final list of 174 medications. In round 1, consensus was reached for 613 (58.7%) statements, with every statement being addressed and scored by the panelists. Panelists provided additional evidence sources for their decisions, and these were distributed to all panel members for round 2. All items were addressed and scored by the panelists. By the conclusion of round 3, consensus had been achieved for 697 (66.8%) statements, with all items being addressed and scored by the panelists.

conclusionsThis study developed consensus-based recommendations for the selection of administration line materials, the use of in-line filtration, and light protection for the administration and storage of a range of medications administered intravenously. The guidance will aid medication stability and efficacy and promote good clinical practice; it currently underpins a prototype bedside app for correct intravenous administration line selection for nursing and pharmacy staff in critical care and oncology units.

Indexed as

Administration, IntravenousFiltrationPractice Guidelines as TopicConsensusDelphi TechniqueHumansPharmacistsadministrationconsensuspanelistspanelsprotectionreviews

Identifiers

PMID42269167
PMCPMC13294651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.